{"id":"W3035149581","doi":"10.1080/14779072.2020.1784007","title":"New pharmacotherapy for heart failure with reduced ejection fraction","year":2020,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dapagliflozin; Sacubitril; Medicine; Valsartan; Ejection fraction; Sacubitril, Valsartan; Heart failure; Angiotensin receptor; Internal medicine; Cardiology; Neprilysin; ACE inhibitor; Pharmacology; Angiotensin-converting enzyme; Angiotensin II; Endocrinology; Blood pressure; Diabetes mellitus; Type 2 diabetes; Enzyme","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005595122,0.000719804,0.005385513,0.0001732727,0.00006823843,0.00002190895,0.0001584279,0.0002178453,0.0003440529],"category_scores_gemma":[0.00002609826,0.0004576419,0.005804063,0.0005665791,0.00003042775,0.000112356,0.00001640236,0.0002879867,0.00005086257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000220996,"about_ca_system_score_gemma":0.0005396973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003681212,"about_ca_topic_score_gemma":3.591632e-7,"domain_scores_codex":[0.9970852,0.0003200041,0.0007959114,0.0007475602,0.0007396126,0.0003117141],"domain_scores_gemma":[0.9981503,0.00006573865,0.0003276556,0.001019217,0.0001882985,0.0002487403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000944383,0.00006908941,1.703522e-7,0.0433591,0.01291263,0.0000114701,0.00002111463,1.695652e-7,0.00001771537,0.00000610527,0.1160718,0.8274361],"study_design_scores_gemma":[0.002424045,0.0006807327,1.429643e-7,0.07403015,0.005639445,0.0001300103,0.0000113931,5.753969e-7,0.0002013398,0.000001263093,0.9165166,0.0003642899],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.129224e-7,0.9787548,0.0090707,0.001880472,0.0002607043,0.009746833,0.000008241262,0.0001257441,0.0001523696],"genre_scores_gemma":[1.238872e-7,0.9691421,0.02559551,0.001397783,0.001676472,0.001523127,0.0002765913,0.0001764169,0.0002118452],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8270719,"threshold_uncertainty_score":0.9997875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03741673991264166,"score_gpt":0.3626582536277812,"score_spread":0.3252415137151395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}